Palisade Bio, Inc. (PALI)

Palisade Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	12.46	12.41	10.52	0.74	5.11
Cash & Cash Equivalents	12.46	12.41	10.52	0.74	5.11
Cash Growth	0.39%	17.95%	1323.68%	-85.55%	-11.62%
Receivables	0	0	0	0.06	0.02
Other Current Assets	0.87	2.32	0.99	0.1	0.51
Total Current Assets	13.33	14.73	11.51	0.9	5.65
Property, Plant & Equipment	0.21	0.31	0.11	0.28	0.27
Goodwill and Intangibles	0	0	0	0	0.67
Other Long-Term Assets	0.52	0.72	0.89	1.84	0
Total Long-Term Assets	0.72	1.03	1.01	2.12	0.94
Total Assets	14.05	15.76	12.51	3.02	6.58
Accounts Payable	0.7	1.76	1.32	2.54	0.82
Current Debt	0.28	0.19	0.2	1.22	0.26
Other Current Liabilities	1.61	1.06	0.97	4.33	0.14
Total Current Liabilities	2.59	3.01	2.5	8.08	1.22
Long-Term Debt	0.09	0.21	0	0.21	0.15
Other Long-Term Liabilities	0.06	0.06	2.65	1.83	0.08
Total Long-Term Liabilities	0.15	0.27	2.65	2.04	0.23
Total Liabilities	2.74	3.28	5.15	10.12	1.46
Total Debt	0.37	0.4	0.2	1.42	0.41
Debt Growth	-8.66%	103.02%	-86.00%	243.89%	89.02%
Retained Earnings	-121.51	-109.19	-94.64	-68.03	-221.98
Comprehensive Income	0	0	0	0	-0.01
Shareholders' Equity	11.31	12.48	7.37	-16.6	5.13
Net Cash / Debt	12.09	12.01	10.32	-0.68	4.7
Net Cash / Debt Growth	0.70%	16.30%	-	-	-15.57%
Net Cash Per Share	26.51	204.56	828.15	-184.37	9634.65
Working Capital	10.74	11.72	9.01	-7.19	4.42
Book Value Per Share	24.81	212.63	593.33	-4488.05	10497.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).